Professional Documents
Culture Documents
TUBERCULOSIS
LINKS:
http://www.tbfacts.org/tb-treatment/
http://www.emedicinehealth.com/tuberculosis/page2_em.htm
http://www.livestrong.com/article/176319-what-are-the-effects-of-tb/
Once infectious particles reach the alveoli (small saclike structures in the air
spaces in the lungs), another cell, called the macrophage, engulfs the TB
bacteria.
o Then the bacteria are transmitted to the lymphatic system and bloodstream
and spread to other organs occurs.
o The bacteria further multiply in organs that have high oxygen pressures, such
as the upper lobes of the lungs, the kidneys, bone marrow, and meninges --
themembrane-like coverings of the brain and spinal cord.
When the bacteria cause clinically detectable disease, you have TB.
People who have inhaled the TB bacteria, but in whom the disease is
controlled, are referred to as infected. Their immune system has walled off the
organism in an inflammatory focus known as a granuloma. They have no
symptoms, frequently have a positive skin test for TB, yet cannot transmit the
disease to others. This is referred to as latent tuberculosis infection or LTBI.
Risk factors for TB include the following:
o HIV infection,
o low socioeconomic status,
o alcoholism,
o homelessness,
o crowded living conditions,
o diseases that weaken the immune system,
o migration from a country with a high number of cases,
o and health-care workers.
EFFECT:
These can include:
OTHER EFFECTS:
If a TB infection is not diagnosed and treated, the infection can be fatal, explains
the Mayo Clinic. The bacteria severely damages the lungs, which causes severe
coughing that may produce blood, wheezing, chest pain and difficulty breathing.
The infection may also cause fever, fatigue and unintentional weight loss. If the
infection is not treated, if the bacteria is drug-resistant or if the infected person
has a weakened immune system from another disease or condition, the damage
to the lungs can become so severe that the person cannot breath properly, which
can lead to death.
Meningitis
If the TB infection spreads to the brain, it can cause meningitis. The infection in
the brain can have several serious effects, including fever, loss of appetite,
listlessness and periods of lost consciousness. In addition, a patient with TB
meningitis may suffer from severe nausea and vomiting, severe headache, neck
stiffness and light sensitivity. Left untreated, TB meningitis can lead to frequent
seizures, muscle paralysis, impaired mental function and abnormal behavior.
Arthirtis
In rare cases, a TB infection may spread to the joints, causing TB arthritis. The
most commonly infected joints include the wrists, ankles, knees, hips and spine.
When the bacteria does spread to a joint, typically only one joint is infected. The
affected joint often suffers from stiffness, swelling, tenderness and a decreased
range of motion. TB arthritis may also cause a fever and excessive sweating,
particularly during the night. The muscles around the joint may experience
spasms and may atrophy over time. If the infection is in the spine, the parts of
body below the infection may feel tingling, numbness or weakness.
Miliary TB
Another rare type of TB is miliary TB, in which the infection spreads throughout
the body. The name miliary arose because the millions of infected spots
throughout the body are roughly the same size as millet--small, round seeds often
found in bird food. This type of infection usually only occurs in people with an
already weakened immune system, such as HIV patients. The bacteria spreads
through the bloodstream and lymph system to infect all parts of the body, causing
symptoms of general ill feeling, fever, chills, weight loss, weakness, difficulty
breathing and anemia.
SYMPTOMS:
Although your body may harbor the bacteria that cause tuberculosis, your
immune system usually can prevent you from becoming sick. For this reason,
doctors make a distinction between:
Latent TB. In this condition, you have a TB infection, but the bacteria remain
in your body in an inactive state and cause no symptoms. Latent TB, also
called inactive TB or TB infection, isn't contagious. It can turn into active TB,
so treatment is important for the person with latent TB and to help control
the spread of TB. An estimated 2 billion people have latent TB.
Active TB. This condition makes you sick and can spread to others. It can
occur in the first few weeks after infection with the TB bacteria, or it might
occur years later.
Signs and symptoms of active TB include:
See your doctor if you have a fever, unexplained weight loss, drenching night
sweats or a persistent cough. These are often signs of TB, but they can also result
from other medical problems. Your doctor can perform tests to help determine
the cause.
The Centers for Disease Control and Prevention recommends that people who
have an increased risk of tuberculosis be screened for latent TB infection. This
recommendation includes:
People with HIV/AIDS
IV drug users
Those in contact with infected individuals
Health care workers who treat people with a high risk of TB
TREATMENT:
TB treatment can cure most people who have TB, using a combination of the
different drugs available for TB treatment. Surgery is sometimes used as
treatment for TB.
Isoniazid
Rifampicin
Pyrazinamide
Ethambutol
and Streptomycin
are those TB drugs that generally have the greatest bactericidal activity when
used for TB treatment. The amount of drug that a TB patient needs to take
depends on the patients weight.
TB treatment for new patients
New patients are those who have not had TB treatment before, or they have
received less than one month of anti TB drugs. New patients are presumed to
have drug susceptible TB (i.e. TB which is not drug resistant) unless:
Isoniazid
plus rifampicin
plus pyrazinamide
plus ethambutol
followed by
Isoniazid
plus rifampicin
for the continuation TB treatment phase.
It is recommended that patients take the TB drugs every day for the six months.
Although taking the drugs three times a week is possible in some circumstances, it
is essential that all the recommended TB drugs are taken. If only one or two drugs
are taken, then the TB treatment probably wont work, because the TB bacteria
that the patient has develops resistance to the drugs. Not only is the patient then
still ill, but to be cured they then have to take drugs for the treatment of drug
resistant TB. These drugs are more expensive and have more side effects.
TB treatment for other patients
A patient may not qualify for treatment as a new patient, for example because
they have had TB treatment before. Then they probably need to take a different
and longer course of drug treatment. If they just have the same course of TB drug
treatment again, they will probably not be cured. The drug regimen or plan will
need to be worked out in the same way as a TB treatment regimen or plan is
worked out for a patient who needs treatment for drug resistant TB.
TB treatment failure
It is often suggested that TB treatment fails because a patient doesnt take their
TB drugs correctly. However there can be a number of different reasons for TB
treatment failure. It is certainly true that if a patient doesnt take their TB drug
treatment properly that this can lead to the development of drug resistant
TB. However the patient may already have drug resistant TB. If they already have
drug resistant TB, then treatment that someone is provided with may result in
treatment failure even if the treatment is taken correctly.
The three main causes of TB treatment failing, relate to the actions of doctors in
prescribing incorrect regimes, the fact that there may be problems with the drugs
being delivered (either when they are delivered or the quality), and that patients
for a number of reasons may not have a sufficient intake of the drugs.4
Doctors as a cause of TB drug treatment failure:
Inappropriate guidelines,
Non compliance with guidelines,
Absence of guidelines.
Drugs as a cause of inadequate TB treatment:
Poor quality,
Irregular supply,
Wrong delivery (dose/combination),
Drugs are unsuitable due to drug resistance.
Patients as a cause of TB drug treatment failure:
Lack of information,
Lack of money for treatment and/or transport,
Actual or presumed side effects,
Lack of commitment to a long course of drugs,
Malabsorption,
Social barriers.
Patients who experience only a short improvement whilst on TB treatment, or
who never respond to treatment, are said to have failed their TB treatment.
Treatment failure is also sometimes defined as the continued presence of positive
sputum or culture (positive result to a culture test) or positive sputum or culture
appears again, during the course of a patients anti tuberculosis drug treatment
(att).5
After three months of multi drug treatment for pulmonary TB caused by drug
susceptible bacteria, 90-95% of patients will have negative sputum or culture and
show clinical improvement. Normally it is considered that if a patient still has a
positive culture after three months of treatment, the patient must be carefully
evaluated to identify why their positive culture hasnt changed to negative.
Patients whose sputum culture remain positive after four months of drug
treatment should be classified as treatment failures. If drug
treatment failure occurs then a sample should be sent to a reference laboratory
for drug susceptibility testing for both first and second line drugs.
TB treatment relapse & recurrence
A patient is said to relapse if they become and remain culture negative (or they
become well) whilst on TB treatment, but become culture positive (or become ill)
again after finishing their TB treatment.
Recurrence of active TB is usually used to refer to the situation when a persons
first TB treatment appears to have been successful. There has then been a
significant time interval before active TB develops again. This may either be
because of reactivation of the persons previously latent TB or because they have
been reinfected. In any of these situations occur it must be considered a real
possibility that the person has drug resistant TB. Their new TB
treatment programme must be decided taking this into account.
TB treatment monitoring